Effect of acarbose and simultaneous antacid therapy on blood glucose

Arzneimittel-Forschung/Drug Research

Volumn 47, Issue 10, 1997, Pages 1108-1111

  Höpfner, Michael ^a   Durani, Benjamin ^a   Spengler, Manfred ^b   Fölsch, Ulrich R ^a  

^a UNIVERSITY OF KIEL   (Germany)

^b BAYER AG   (Germany)

Author keywords

Acarbose, drug interaction; Antacids; Bay g 5421; CAS 56180 94 0; Diabetes mellitus; Glucobay 100

Indexed keywords

ACARBOSE; ALUMINUM MAGNESIUM HYDROXIDE; ANTACID AGENT; PLACEBO;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG INTERACTION; FLATULENCE; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; INSULIN BLOOD LEVEL; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PHARMACODYNAMICS; POSTPRANDIAL STATE; RANDOMIZED CONTROLLED TRIAL; VOLUNTEER;

ACARBOSE; ADOLESCENT; ADULT; ALUMINUM HYDROXIDE; ANTACIDS; AREA UNDER CURVE; BLOOD GLUCOSE; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; DRUG INTERACTIONS; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MAGNESIUM HYDROXIDE; MALE; TRISACCHARIDES;

EID: 0030826896     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Fölsch, U. R., Lembeke, B., Internist 32, 699 (1991)
2. Puls, W., Keup, U., Krause, H. P. et al., Naturwissenschaften 64, 536 (1977)
3. Schmidt, D. D., Frommer, W., Junge, B. et al., Naturwissenschaften 64, 535 (1977)
4. Creutzfeldt, W. (ed.), First International Symposium on Acarbose: effects on carbohydrate and fat metabolism. Excerpta Medica ICS, Amsterdam-Oxford-Princeton (1982)
5. Kurtz, W., Gü ldütuna, S., Leuschner, U., Z. Gastroenterol. 27, 270 (1989)
6. Lipsett, P., Gadacz, T. R., J. Surg. Res. 47, 403 (1989)
7. Konturek, S. J., J. Physiol. Pharmacol. 44, 5 (1993)
8. Deppermann, K. M., Lode, H., Höffken, G. et al., Antimicrob. Agents Chemother. 33, 1901 (1989)
9. Granneman, G. R., Stephan, U., Birner, B. et al., Clin. Pharmacokinet. 22, 83 (1992)
10. Höffken, G., Deppermann, K. M., Lode, H. et al., Klin. Wschr. 65 (Suppl. IX), 28 (1987)
11. Kraynak Roush, M. C., Dupuis, R. E., Ann. Pharmacother. 25, 473 (1991)
12. Lazzaroni, M., Imbimbo, B. P., Bargiggia, S. et al., Antimicrob. Agents Chemother. 37, 2212 (1993)
13. Liel, Y., Sperber, A. D., Shany, S., Am. J. Med. 97, 363 (1994)
14. Nix, D. E., Wilton, J. H., Ronald, B. et al., Antimicrob. Agents Chemother. 34, 432 (1990)
15. Pfeifer, S., Pharmazie 50, 307 (1995)
16. Jones. B., Kennward, M. G. (eds.), Design and analysis of cross-over trials. Chapman and Hall, London (1989)
17. Ammon, H. P. T., Diab. Stoffw. 5, 409 (1995)
18. Hanefeld, M., Fischer, S., Schulze, J. et al., Diabetes Care 14, 732 (1991)
19. Dimitriadis, G. D., Tessari, P., Go., V. L. W. et al., Dtsch. Ärztebl. 82, 1413 (1985)
20. Gérard, J., Luyckx, A. S., Lefebvre, P. J., Diabetologia 21, 446 (1981)
21. Sachse, G., Willms, B., Diabetologia 17, 287 (1979)